Analysis reveals photobiomodulation enhances cerebrospinal fluid flow in healthy individuals, indicating melanin's role.
Motivation: The use of photobiomodulation (PBM) to enhance glymphatic drainage and thus neurotoxic waste clearance, makes it a promising therapeutic tool against neurodegenerative diseases like Alzheimer's. Goal(s): This study investigates whether PBM can modulate cerebrospinal fluid (CSF) flow in healthy young adults. Approach: Adjusting key parameters like wavelength, frequency, and power will determine the most effective PBM protocol. Results: Our data demonstrates 4 min of PBM-induced increases in CSF flow, greater for higher power density, lower wavelength and pulsation frequency. Intranasal PBM achieved similar performance as transcranial PBM, albeit with 1/20 the power. Participant melanin levels also impact PBM's effect on CSF flow. Impact: Photobiomodulation (PBM) has shown to enhance glymphatic drainage by modulating CSF flow, but in a delivery and dose-dependent manner. The significant wavelength-frequency interactions and melanin effects demonstrate the need to optimize PBM delivery in different settings.
No takes yet. Share an insight, caveat, or question.
Motsenyat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: